TSE:PJC.A

Jean Coutu Group (PJC.A) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
664,286 shs
Average Volume
126,739 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
PJC.A stock logo

About Jean Coutu Group Stock (TSE:PJC.A)

The Jean Coutu Group (PJC) Inc. is a Canada-based company, which is engaged in franchising pharmacy chains. The Company operates through two segments: franchising and generic drugs. Within the franchising segment, the Company carries on the franchising activity under the banners of PJC Jean Coutu, PJC Clinique, PJC Jean Coutu Sante and PJC Jean Coutu Sante Beaute; operates approximately two distribution centers, and coordinates various other services for its franchisees. In the generic drugs segment, the Company owns Pro Doc Ltd, a Canadian manufacturer of generic drugs whose revenues come from the sale of generic drugs to wholesalers and pharmacists. The Company has approximately 420 PJC franchised stores in Quebec, Ontario and New Brunswick. The Company's services to its franchisees include centralized purchasing, distribution, marketing, training, human resources, management, operational consulting and information systems, as well as a private label program.

PJC.A Stock News Headlines

Y-Jean Mun-Delsalle
The World's First "$20 Trillion Drug?"
One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!
The World's First "$20 Trillion Drug?"
One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!
Jean-Luc Godard Will Be Modern Forever
Tilray Inc. (TSX: TLRY)
See More Headlines
Receive PJC.A Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Jean Coutu Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Jean Coutu
    Chairman of the Board
  • Francois Jean Coutu
    President, Chief Executive Officer, Non-Independent Director
  • Nicolle Forget QC
    Independent Vice Chairman of the Board
  • Marcel A. Raymond
    President of Pro-Doc Ltee
  • Andre Belzile
    Executive Vice President - Finance and Corporate Affairs
  • Alain Lafortune
    Executive Vice President - Purchasing and Marketing
  • Jean-Michel Coutu
    Executive Vice President - Retail Operations and Distribution
  • Richard Mayrand
    Executive Vice President - Pharmacy and Governmental Affairs
  • Normand Messier
    Executive Vice President - Franchise Development and Operations
  • Alain Boudreault
    Chief Information Officer, Vice President

This page (TSE:PJC.A) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners